The National Health Surveillance Agency (Anvisa) released a note saying that it was formally informed about the death of a volunteer from the Oxford vaccine tests. “Data related to the investigation carried out by the International Security Assessment Committee were shared with the Agency. It is important to note that, based on the ethical confidentiality commitments provided for in the protocol, the regulatory agencies involved receive partial data regarding the investigation carried out by that committee. , which he suggested for the continuation of the study “, said Anvisa, in a note.
A Brazilian volunteer who participated in clinical trials of the vaccine developed by Oxford University and the laboratory AstraZeneca died due to complications of covid-19, last Thursday (15). There is no confirmation whether he received a placebo or a dose of the immunizer.